Keywords: نقطه توقف; Antimicrobial susceptibility testing; Breakpoints; Carbapenems; Pseudomonas aeruginosa; Tests de sensibilité aux antibiotiques; Concentrations critiques; Carbapénèmes; Pseudomonas aeruginosa;
مقالات ISI نقطه توقف (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نقطه توقف; Antibacterial; Breakpoints; Gram-positive; Susceptibility criteria; Tedizolid;
Keywords: نقطه توقف; Blood alcohol concentration; Breakpoints; Quinine adulteration; Alcohol drinking; Ethanol;
Keywords: نقطه توقف; ADHD; Attention Deficit and Hyperactivity Disorder; ACMG; American College of Medical Genetics; AR; Autosomal Recessive; ASD; Autism Spectrum Disorders; aCGH; array Comparative Genomic Hybridization; BP; BreakPoints; CK1; Casein- Kinase 1; CdLS; Cornelia
Keywords: نقطه توقف; Copy number alterations; Jitter distribution; Breakpoints;
Keywords: نقطه توقف; Asymptotic normality; Breakpoints; Changepoints; Infill asymptotics; Linear model
Keywords: نقطه توقف; Breakpoints; Dynamic programming; Social media; LIWC; Dynamics of emotions; Twitter;
Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media
Keywords: نقطه توقف; Antimicrobial susceptibility testing; Breakpoints; Broth microdilution; Disk diffusion; EUCAST; Kingella kingae;
Puntos de corte de dalbavancina y recomendaciones para el estudio de su actividad in vitro
Keywords: نقطه توقف; Dalbavancina; Lipoglucopéptidos; Punto de corte; Valor subrogado; Dalbavancin; Lipoglycopeptides; Breakpoints; Subrogate value;
Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints
Keywords: نقطه توقف; Third-generation cephalosporins; Empirical therapy; Bacteraemia; Enterobacteriaceae; Clinical and Laboratory Standards Institute; Breakpoints;
EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents
Keywords: نقطه توقف; Antifungal susceptibility testing; breakpoints; isavuconazole; itraconazole; QC MIC ranges;
The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds
Keywords: نقطه توقف; Antifungal resistance; Breakpoints; EUCAST; CLSI; ECVs/ECOFFsResistencia antifungica; Puntos de corte; EUCAST; CLSI; ECVs/ECOFFs
Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates
Keywords: نقطه توقف; Bacteroides fragilis group; Susceptibility testing; Disc diffusion; MIC determination; Breakpoints
The mitigating effect of strategic behavior on the net benefits of a direct load control program
Keywords: نقطه توقف; Q41; Q5; L94; Demand response; Pre-cooling; Snapback; Strategic behavior; Breakpoints;
Novel method to obtain the optimal polygonal approximation of digital planar curves based on Mixed Integer Programming
Keywords: نقطه توقف; Polygonal approximation; Digital planar curve; Mixed Integer Programming; Discrete optimization; Dominant points; Breakpoints; Integral square error; Optimization
Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
Keywords: نقطه توقف; Pharmacokinetics; Pharmacodynamics; PK/PD analysis; Monte Carlo simulation; Breakpoints
The computation of polygonal approximations for 2D contours based on a concavity tree
Keywords: نقطه توقف; Digital planar curves; Polygonal approximation; Dominant points; Concavity tree; Breakpoints; Merge methods; Split methods; Convex hull
Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Keywords: نقطه توقف; Echinocandins; Azoles; Acquired resistance; Susceptibility testing; Breakpoints; EUCAST; CLSI; MIC; Candida; Aspergillus;
EUCAST expert rules in antimicrobial susceptibility testing
Keywords: نقطه توقف; Antimicrobial susceptibility testing; breakpoints; EUCAST; expert rules; interpretive reading;
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli
Keywords: نقطه توقف; Bloodstream infections; breakpoints; cephalosporins; Escherichia coli; extended-spectrum β-lactamases; therapy
Localization of centromeric breaks in head and neck squamous cell carcinoma
Keywords: نقطه توقف; Head and neck squamous cell carcinoma; chromosome instability; centromere; whole-arm translocation; breakpoints
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
Keywords: نقطه توقف; Breakpoints; eucast; pharmacodynamics; pharmacokinetics; susceptible
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium
Keywords: نقطه توقف; Streptococcus pneumoniae; β-Lactams; Macrolides; Fluoroquinolones; Community-acquired pneumonia; Serotyping; Vaccine; EUCAST; CLSI; Breakpoints
In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints
Keywords: نقطه توقف; Ceftobiprole; New cephalosporin; In vitro activity; Breakpoints;
Girth of pancake graphs
Keywords: نقطه توقف; Pancake graphs; Girth; Reversals; Breakpoints
Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro?
Keywords: نقطه توقف; Breakpoints; inappropriate treatment; resistance; S. aureus; therapy
Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimi
Keywords: نقطه توقف; SENTRY; Antifungal agents; Resistance; Breakpoints; Candida spp.; CLSI
Control of onchocerciasis in Africa: Threshold shifts, breakpoints and rules for elimination
Keywords: نقطه توقف; Africa; Epidemiology; Onchocerciasis; Elimination; Mathematical model; Breakpoints;
Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
Keywords: نقطه توقف; PK/PD; Emergence resistance; Breakpoints; Drug development
Current trends in the analysis of Canadian productivity growth
Keywords: نقطه توقف; Productivity growth; Detrending; Breakpoints; Structural change; Data revision
Aspectos farmacocinéticos y farmacodinámicos para la lectura interpretada del antibiograma
Keywords: نقطه توقف; Puntos de corte; Farmacocinética; Farmacodinamia; Breakpoints; Pharmacokinetics; Pharmacodynamics;
Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future
Keywords: نقطه توقف; Antimicrobial resistance; Susceptibility testing; Data collection; Breakpoints; Harmonization;
In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints
Keywords: نقطه توقف; Tigecycline; In vitro activity; Susceptibility; Multidrug resistance; Breakpoints
Breakpoints in annual rainfall trends in Córdoba, Argentina
Keywords: نقطه توقف; Rainfall; Climate change; Trend; Breakpoints
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints
Keywords: نقطه توقف; breakpoints; cephalosporins; CLSI; Enterobacteriacae; EUCAST; review
Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines
Keywords: نقطه توقف; Moxifloxacin; Anaerobes; Susceptibility testing; MIC; Breakpoints
A proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens
Keywords: نقطه توقف; Antibiotic therapy; Breakpoints; Swine; Respiratory diseases; Amoxicillin
Structural changes of volcanic tremor at Stromboli volcano
Keywords: نقطه توقف; Stromboli; volcanic tremor; structural changes; breakpoints; R package
The contribution of pharmacokinetic–pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis
Keywords: نقطه توقف; Breakpoints; interpretative susceptibility criteria; Monte Carlo simulation; Neisseria meningitidis; pharmacokinetics–pharmacodynamics; susceptibility testing
A novel Univariate Marginal Distribution Algorithm based discretization algorithm
Keywords: نقطه توقف; Univariate Marginal Distribution Algorithm; Breakpoints; Discretization; Estimation of Distribution Algorithms; Data mining;
The distribution of HIV-1 recombination breakpoints
Keywords: نقطه توقف; HIV-1; AIDS; Recombination; Breakpoints; Strand-switching;
The advantages of the use of discs containing single agents in disc diffusion testing of the susceptibility of Aeromonas salmonicida to potentiated sulphonamides
Keywords: نقطه توقف; Antimicrobial susceptibility; Aeromonas salmonicida; Disc diffusion; Trimethoprim/sulfamethoxazole; Breakpoints; Normalised resistance interpretation;
Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae
Keywords: نقطه توقف; Fluoroquinolones; Breakpoints; Streptococcus pneumoniae
Breakpoints for disc diffusion susceptibility testing of bacteria associated with fish diseases: A review of current practice
Keywords: نقطه توقف; Antimicrobial susceptibility; Disc diffusion; Breakpoints; Finfish; PANDA
Overview of the Potency of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®)
Keywords: نقطه توقف; antibiotic; breakpoints; fluoroquinolone in vitro; in vivo; MIC; moxifloxacin; pharmacodynamics; pharmacokinetic; potency; MPC; therapeutic index; VIGAMOX®;
A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit
Keywords: نقطه توقف; breakpoints; Monte Carlo simulation; probability of target attainment; ceftazidime; PK/PD;
Susceptibility testing accuracy of a CTX-M-type extended-spectrum β-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 β-lactams
Keywords: نقطه توقف; ESBL; Enterobacteriaceae; CLSI/NCCLS; Breakpoints; Intermethod errors;